A set of 13 alkyl derivatives of 3-phenylpiperidine-2,6-dione were synthesized. Newly obtained compounds were investigated in vitro against HIV-1 and other selected viruses. The benzyl 3f and fluorophenyl 3g derivatives showed moderate protection against CVB-2 and the compound 3g also against HSV-1. Derivatives were tested also for their antibacterial and antifungal activity. The molecular structures of 3a and 3d were determined by an X-ray analysis.
Introduction
Literature survey shows that phenylpiperazinyl group is a nuclei of antiviral, antibacterial and antifungal [1] [2] [3] agents. It could be integrated with imidazole [4, 5] , 1,8-naphthyridone [6] , furan [7] , 1,4-dithiine [8] or quinolone [9] rings. N-alkyl and N-aryl piperazines are also present as phosphonate [10] and cyano [11] derivatives. Short-chain p-substituted aryl piperazines are found as active against Staphylococcus aureus and Pseudomonas aeruginosa [12, 13] . Recently, derivatives of diarylpiperidin-4-one were found as the new class of antimicrobial agents with activity against pathogenic bacterial species and fungal
Results and discussion
The preparation of new thirteen 3-phenylpiperidine-2,6-dione derivatives is described. The general synthetic pathway and structure of the investigated compounds is given in Fig. 2 . The starting imide 2 was obtained from 2-phenylglutaric anhydride in reaction with ammonium carbonate. Next the compound was subjected to the reaction with 1,4-dibromobutane and 1,3-dibromopropane in order to be transformed into the corresponding alkyl derivatives 3 and 4. Next these compounds were condensed with appropriate amines to yield compounds 3a-3g and 4a-4c. Obtained N-substituted derivatives were purified by column chromatography. Elemental analysis and 1 H NMR spectra confirmed the identity of the product. The molecular structure of 3a and 3d was established by the crystal structure analysis (Fig. 1) . Moreover, the two crystals are hemihydrates with a high degree of isostructurality, viz. they have the same symmetry, similar mode of molecular packing and noncovalent interactions. Very characteristic feature is: (a) the O-H…N hydrogen bond formed between the water molecule and the piperazine N1-atom, and (b) the lack of hydrophobic interactions of both the methoxy group (3a) and pyridine N-atom (3d). >100  3f  96  >96  >96  >96  44  >96  3g  92  31  >92  >92  44  >92  4a  >100  >100  >100  >100  >100  >100  4b  98  >98  >98  >98  >98  >98  4c  >100  >100  >100  >100  >100  >100  4d  >100  >100  >100  >100  >100  >100  NM 176*  23 18 M 5255** 1.8 ACG*** 3 Antiviral activity is given as EC 50 (Median Effective Concentration -the concentration of a drug (μM) required to induce a 50% effect), and cytotoxicity is given as CC 50 (Cytotoxic Concentration -the amount of a drug (μM) at which 50% of cells become dead). For biochemical studies N-substituted alkyl derivatives were converted into their hydrochlorides. Compounds 3a and 3d were presented as monohydrochlorides and 3b, 3c, 3e, 3f, 3g, 4a, 4b, 4d as dihydrochlorides.
Ten compounds, N-substituted derivatives of 3-phenylpiperidine-2,6-dione, were evaluated in vitro against viruses, bacteria and fungi.
Title compounds were evaluated for antiviral activity against viruses representative of two of the three genera of Flaviviridae family, that is, Flaviviruses (Yellow Fever Virus, YFV) and Pestiviruses (Bovine Viral Diarrhoea Virus, BVDV), as Hepaciviruses can hardly be used in routine cell-based assays. Compounds were also tested against representatives of other virus families. Among ssRNA+ were a retrovirus (human immunodeficiency virus type 1, HIV-1) and two Picornaviruses (Coxsackie Virus type B2, CVB-2 and Poliovirus type-1, Sabin strain, Sb-1); among ssRNA-were a Rhabdoviridae (Vesicular Stomatitis Virus, VSV) representative. Among double-stranded RNA (dsRNA) viruses was a Reoviridae representative (Reo-1). Two representatives of DNA virus families were also included: Herpes Simplex type-1, HSV-1 (Herpesviridae) and Vaccinia Virus, VV (Poxviridae).
In addition to the antiviral activity, compounds were evaluated in vitro against representative strains of Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Pseudomonas aeruginosa), yeasts and moulds (Candida albicans and Aspergillus niger).
AZT (3'-azidothymidine), NM 108 (2'-ß-methylguanosine), NM 176 (2'-ethynylcitidine), M 5255 (Mycophenolic Acid) and ACG (acycloGuanosine) were used as reference inhibitors of ssRNA+, ssRNA-and DNA viruses, respectively.
Two of tested derivatives presented moderate antiviral activity ( Table 1 ). The CVB-2 cells were susceptible to benzyl (3f) and 1-(4-fluorophenyl)-substituted (3g) long-chain arylpiperazine derivatives. The fluorophenyl derivative was also active against HSV-1 virus. The 50% cytotoxic concentration (CC 50 ) of this compound in Vero-76 cells was 92 µM. The range of cytotoxicity of compounds in MT-4 cells was from 100 to 54 µM.
Tab. 2.
Antibacterial and antifungal activities of 3-phenylpiperidine-2,6-dione and its derivatives. Gram-negative rods as well as gram-positive strains and fungal organisms were resistant to all tested agents. Their minimal inhibitory concentration (MIC) values for all compounds were above 100 µM (Table 2) . However, none of title compounds turned out to be active against HIV-1, BVDV or representatives of ssRNA-and dsRNA viruses.
Theoretical calculated lipophilicity (logP) of synthesized compounds ranged from 1.89 to 3.92. According to Clark and Lobell rules [21] , all derivatives could cross the blood-brain barrier to act as ligands of receptors of central nervous system.
Experimental

Chemistry
All chemicals and solvents were purchased from Aldrich (Vienna, Austria). Melting points were determined on an Electrothermal Digital Melting Point Apparatus (Essex, UK) and are uncorrected. The 1 H-NMR spectra were recorded on a Bruker (Rheinstetten, Germany) spectrometer, operating at 400 or 300 MHz. The chemical shift values are expressed in ppm relative to TMS as an internal standard. Elemental analyses were recorded on a CHN model 2400 Perkin-Elmer (Hitachi, Tokyo, Japan). TLC was carried out using silica gel 60 F 254 , layer thickness 0.25 mm (E. Merck, Darmstadt, Germany) and the results were visualized using UV lamp at 254 nm. Column chromatography was carried out using silica gel 60 (200-400 mesh, Merck).
The elemental analyses and
1 H-NMR spectra, as well as melting points are given for dihydrochlorides (except for compounds 3, 4, 3a and 3d). Yields are presented for crude products.
LogP values for arylpiperazine derivatives were calculated using ChemBioDrawUltra 12.0. (http://www.cambridgesoft.com).
Molecular structure of 3a and 3d was confirmed by an X-ray crystallography ( Table 3 ). The intensity data were collected at room temperature with a KM4 diffractometer using graphite monochromated CuKα radiation (λ = 1.54178 Å) and ω -2θ scan mode. Both compounds crystallized as hemihydrates and their crystals were of poor quality. Structure was solved by the SHELXS-97 program and refined by full-matrix least-squares on F 2 using the SHELXL-97 program [18] . Non-hydrogen atoms were refined with anisotropic displacement parameters, except those of phenyl rings of 3a. The H-atoms of molecules 3a and 3d were positioned geometrically and 'riding' model was used in the refinement, while H-atoms of water molecules were located on difference maps. Crystallographic data had been deposited with the Cambridge Crystallographic Data Center.
3-Phenylpiperidine-2,6-dione (2)
A mixture of 2-phenylglutaric anhydride (0.0165 mol) and (NH 4 ) 2 CO 3 (0.125 mol) was reduced to powder and heated up to 185 °C using a metal bath of Wood's alloy. When CO 2 and NH 3 were completely liberated, 10 cm 3 of paraffin oil was added and whole mixture was heated until the evolution of gas ceased. The residue was crystallized from hexane and ethyl acetate; mp 143 °C (mp 142-143 from methanol [23] ).
Tab. 3.
Crystal data and parameters of the data collection and refinement for crystals of 3a⋅½ H 2 O and 3d⋅½ H 2 O. 
General method for preparation of 1-(alkyl)-3-phenylpiperidine-2,6-diones 3 and 4
A mixture of imide 2 (1.5 g, 0.008 mol), 1,4-dibromobutane (0.02 mol) and 1,3-dibromopropane (0.02 mol), respectively, anhydrous K 2 CO 3 (1.5 g) and catalytic amount of 98% 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) were refluxed in acetone for 60-70 h. Then, the solvent was removed on a rotary evaporator and the oily residue was purified by column chromatography (chloroform : methanol 9.5:0.5 vol).
1-(4-Bromobutyl)-3-phenylpiperidine-2,6-dione (3)
Yield: 78%, mp 138. General method for the preparation of 1-[4-aryl/heteroarylpiperazin-1-ylbutyl)  (3a-3g) and 1-[3-aryl/heteroarylpiperazin-1-ylpropyl) (4a-4c) derivatives of 3-phenylpiperidine-2,6-dione A mixture of derivative 3 (0.3 g, 0.001 mol) and 4 (0.3 g, 0.001 mol), respectively, the corresponding amine (0.002 mol), anhydrous K 2 CO 3 (0.3 g) and catalytic amount of KI was refluxed in acetone for 30 h. Then the mixture was filtered off and the solvent was evaporated. The residue was purified by column chromatography (chloroform : methanol 9.5:0.5 vol) and/or crystallized from hexane.
Obtained compounds were converted into their hydrochlorides. The solid product was dissolved in methanol saturated with gaseous HCl. The hydrochloride was precipitated by addition of diethyl ether. The crude product was crystallized from methanol/ethyl ether.
1-{4-[4-(2-Methoxyphenyl)piperazin-1-yl]butyl}-3-phenylpiperidine-2,6-dione (3a)
Mp 210 °C from acetone (mp (salt) from acetone 209-210 °C) [20] . LogP = 3.64.
3-Phenyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione (3b)
Yield: 70%, mp 210-212 °C. 
1-{4-[4-(2-Hydroxyphenyl)piperazin-1-yl]butyl}-3-phenylpiperidine-2,6-dione (3c)
Yield: 67%, mp 234-236 °C. 
3-Phenyl-1-[4-(4-pyridin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione (3d)
Yield: 62%, mp 102-104 °C. 
3-Phenyl-1-[4-(4-phenylpiperazin-1-yl)butyl]piperidine-2,6-dione (3e)
1-{4-[4-(4-Fluorophenyl)piperazin-1-yl]butyl}-3-phenylpiperidine-2,6-dione (3g)
Yield: 73%, mp 178-180 °C. 
1-{3-[4-(2-Methoxyphenyl)piperazin-1-yl]propyl}-3-phenylpiperidine-2,6-dione (4a)
Yield: 63%, mp 178-180 °C. 
3-Phenyl-1-[3-(4-pyrimidin-2-ylpiperazin-1-yl)propyl]piperidine-2,6-dione (4b)
Yield: 60%, mp 214-216 °C. 
1-{3-[4-(2-Hydroxyphenyl)piperazin-1-yl]propyl}-3-phenylpiperidine-2,6-dione (4c)
Yield: 65%, mp 158-160 °C. 
3-Phenyl-1-[3-(4-pyridin-2-ylpiperazin-1-yl)propyl]piperidine-2,6-dione (4d)
Yield: 70%, mp 116-118 °C. 
Microbiological assays
Compounds
Compounds were dissolved in DMSO at 100 mM and then diluted in culture medium.
Cells and Viruses
Cell lines were purchased from American Type Culture Collection (ATCC). The absence of mycoplasma contamination was checked periodically by the Hoechst staining method. Cell lines supporting the multiplication of RNA viruses were the following: CD4 + human T-cells containing an integrated HTLV-1 genome (MT-4) ; Madin Darby Bovine Kidney (MDBK); Baby Hamster Kidney (BHK-21) and Monkey kidney (Vero 76) cells.
Bacterial strains
The antibacterial activity of compounds was tested against collection strains representative of Gram-positive bacteria (Staphylococcus aureus DSM 2569) and Gram-negative bacteria (Pseudomonas aeruginosa DSM 1117). Antifungal activity was tested against collection strains representative of yeasts (Candida albicans DSM 1386) and moulds (Aspergillus niger DSM 1988).
Cytotoxicity Assays
For cytotoxicity tests, run in parallel with antiviral assays, MDBK, BHK and Vero 76 cells were resuspended in 96 multiwell plates at an initial density of 6 x 10 5 , 1 x 10 6 and 5 x 10 5 cells/mL, respectively, in maintenance medium, without or with serial dilutions of tested compounds. Cell viability was determined after 48-120 hrs at 37 °C in a humidified CO 2 (5%) atmosphere by the MTT method. The cell number of Vero 76 monolayers was determined by staining with the crystal violet dye.
For cytotoxicity evaluations, exponentially growing cells derived from human haematological tumors [CD4 + human T-cells containing an integrated HTLV-1 genome (MT-4)] were seeded at an initial density of 1 x 10 5 cells/mL in 96 well plates in RPMI-1640 medium, supplemented with 10% fetal calf serum (FCS), 100 units/mL penicillin G and 100 µg/mL streptomycin. Cell cultures were then incubated at 37 °C in a humidified, 5% CO 2 atmosphere in the absence or presence of serial dilutions of test compounds. Cell viability was determined after 96 hrs at 37 °C by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) method [24] . -well plates at a density of 2 x 10 5 cells/well and were allowed to form confluent monolayers by incubating overnight in growth medium at 37 °C in a humidified CO 2 (5%) atmosphere. Then, monolayers were infected with 250 µL of proper virus dilutions to give 50-100 PFU/well. Following removal of unadsorbed virus, 500 µL of Dulbecco's modified Eagle's medium, supplemented with 1% inactivated FCS and 0.75% methyl cellulose, without or with serial dilutions of test compounds, were added. Cultures were incubated at 37 °C for 2 (Sb-1 and VSV) or 3 (CVB-2, VV and HSV-1) and then fixed with PBS containing 50% ethanol and 0.8% crystal violet, washed and air-dried. Plaques were then counted. 50% effective concentrations (EC 50 ) were calculated by linear regression technique.
Antibacterial and antifungal assays
The antibacterial and antifungal activities were evaluated by determining the Minimum inhibitory concentration (MIC) by the broth microdilution procedure.
Bacterial strains were grown on Tryptic soy agar at 37 °C for 1 day. Cell suspensions of these recent cultures were prepared in sterile 0.85% saline solution by 4-5 colonies. The turbidity of the suspensions was adjusted to the McFarland 0.5 standard. Suspensions were diluted in cation-supplemented Mueller-Hinton broth. For each microorganism, 100 µL of the fivefold serial dilutions of the compounds in cation-supplemented MuellerHinton broth and 100 µL of inoculum were added to each well of a microdilution plate (final titre 5 x 10 5 CFU/mL). The inoculated plates were incubated at 37 °C in non-CO 2 incubator and humid atmosphere. The MICs were determined after 16-20 h [25] .
Fungal strains were grown on Sabouraud's dextrose agar at 35 °C for 1-5 days. Suspensions of these recent cultures were prepared in sterile saline solution (NaCl 0.85%). Suspensions were then diluted in Sabouraud's dextrose broth. 100 µL of the fivefold serial dilutions of the compounds in Sabouraud's dextrose broth and 100 µL of inoculum were added to each well of a microdilution plate (C. albicans 1 x 10 4 cell/mL; A. niger OD 600 0.05). The inoculated plates were incubated at 35 °C in non-CO 2 incubator and humid atmosphere. The MICs were determined after 24 and 48 h.
The concentration of each inoculum was confirmed by viable counts on agar plates by plating the appropriate dilution of the growth control well, immediately after inoculation, and incubating until visible growth. MIC corresponded to the lowest concentration of an antimicrobial compound that showed complete growth inhibition.
Linear regression analysis
Viral and cell growth at each drug concentration was expressed as percentage of untreated controls and the concentrations resulting in 50% (EC 50 , CC 50 ) growth inhibition were determined by linear regression analysis.
